Arvinas Inc ARVN Q1 2026 Earnings Narrower Loss Beats Expectations as Clinical Pipeline Advances Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations GROW Q1 2026 Earnings Profitability Surprises with EPS of 023 Despite No Revenue Disclosure Teekay Tankers Ltd Q1 2026 Earnings EPS Surpasses Estimates by 106 Amidst Robust Tanker Markets BWEN Q1 2026 Earnings NarrowerthanExpected Loss Fails to Boost Sentiment Fonar Corporation FONR Holds Steady Near Support as Technical Indicators Signal Caution Barinthus Biotherapeutics BRNS Edges Higher Small Uptick in LowPriced Stock Gray Media GTN Advances 147 as Stock Challenges Key Resistance Level Haemonetics HAE Slips Modestly as Stock Tests Support Near 63 CRH Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment